Novel therapies for HFmrEF and HFpEF aim to improve symptom management and patient outcomes, addressing current treatment limitations. Emerging treatments could reduce hospitalization rates and ...

Javed Butler, MD, MPH, MBA, discusses the current mineralocorticoid receptor antagonists (MRAs) used for heart failure (HF) with midrange ejection fraction (EF) and HF with preserved EF ...

No matter how many times you have done it, it’s an incredible feeling to publish an article. Seeing months, maybe years of hard work finalised, ready to go out into the world and earn recognition, is ...

These findings have led to strong guideline recommendations for their use in HFrEF. However, their efficacy in HFmrEF or ...

No randomized controlled trial has yet demonstrated a statistically significant reduction in mortality in HFmrEF or HFpEF ...

The findings, he added, support current guidelines that encourage physicians to “leverage” episodes of worsening heart failure, and heart failure hospitalizations in particular, as a good time to ...

why there is a need for the guideline the areas the guideline will and will not cover what it intends to achieve. A draft scope is provided to organisations with an interest in the topic (known as ...

Most of our top stories this month stemmed from the ESC Congress—a mix of drug and device trials as well as guidelines.

This webpage covers all NICE’s guidelines on mental health. The table presents the guidelines alphabetically. Updates planned or in progress and areas we’re actively monitoring are listed for each ...

The new European Society of Cardiology (ESC) Guidelines, co-authored by researchers from the University of Surrey, also highlight that personalised treatment plans, which can include a simple ...

As former members of the expert committee that oversees the science for the U.S. Dietary Guidelines, we can tell you that these chronic diseases are primarily driven by poor diet, and our ...